JSPR

Jasper Therapeutics, Inc.

20.46 USD
-0.46 (-2.20%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Jasper Therapeutics, Inc. stock is down -11.77% since 30 days ago. The next earnings date is Aug 9, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 20% of the previous 4 July’s closed higher than June. In the last 3 Unusual Options Trades, there were 1 PUT, 2 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
31 May 18:44 18 Oct, 2024 22.50 PUT 56 0
12 Jun 19:11 17 Jan, 2025 15.00 CALL 20 10
11 Jul 19:52 21 Mar, 2025 15.00 CALL 25 61

About Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering. The company is based in Redwood City, California.

  • BTIG
    Mon Jul 8, 06:50
    buy
    initial
  • Stifel
    Thu Jun 27, 05:54
    buy
    initial